From the *Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA; †Washington State Department of Labor and Industries, Olympia, WA; and Departments of ‡Psychiatry and Behavioral Sciences, §Rehabilitation Medicine, and ¶Health Services, University of Washington, Seattle, WA.
Acknowledgment date: July 2, 2007. Revision date: October 12, 2007. Acceptance date: October 16, 2007.
The device(s)/drug(s) is/are FDA-approved or approved by corresponding national agency for this indication.
Federal funds were received in support of this work. No benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript.
Supported by the Centers for Disease Control and Prevention National Institute for Occupational Safety and Health grant no. 1 R01 OH04069.
Address correspondence and reprint requests to Gary M. Franklin, MD, MPH, Department of Environmental and Occupational Health Sciences, University of Washington, 1914 N. 34th Street, 101, Seattle, WA 98103; E-mail: [email protected]
